Ignite Creation Date:
2025-12-24 @ 2:43 PM
Ignite Modification Date:
2026-02-01 @ 2:11 PM
Study NCT ID:
NCT00330759
Status:
COMPLETED
Last Update Posted:
2022-11-07
First Post:
2006-05-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.
Sponsor:
Amgen
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Bone Metastases | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Bone metastases | View |
| None | lytic bone lesions | View |
| None | advanced cancer | View |
| None | multiple myeloma | View |
| None | lymphoma | View |
| None | solid tumors | View |
| None | skeletal related events | View |
| None | skeletal fractures | View |
| None | spinal cord compressions, radiation to bone | View |
| None | surgery to bone, bisphosphonates | View |
| None | denosumab | View |